Literature DB >> 20620594

Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array--comparative genomic hybridization.

Anna Isinger-Ekstrand1, Jan Johansson, Mattias Ohlsson, Princy Francis, Johan Staaf, Mats Jönsson, Ake Borg, Mef Nilbert.   

Abstract

We aimed to characterize the genomic profiles of adenocarcinomas in the gastroesophageal junction in relation to cancers in the esophagus and the stomach. Profiles of gains/losses as well as gene expression profiles were obtained from 27 gastroesophageal adenocarcinomas by means of 32k high-resolution array-based comparative genomic hybridization and 27k oligo gene expression arrays, and putative target genes were validated in an extended series. Adenocarcinomas in the distal esophagus and the gastroesophageal junction showed strong similarities with the most common gains at 20q13, 8q24, 1q21-23, 5p15, 13q34, and 12q13, whereas different profiles with gains at 5p15, 7p22, 2q35, and 13q34 characterized gastric cancers. CDK6 and EGFR were identified as putative target genes in cancers of the esophagus and the gastroesophageal junction, with upregulation in one quarter of the tumors. Gains/losses and gene expression profiles show strong similarity between cancers in the distal esophagus and the gastroesophageal junction with frequent upregulation of CDK6 and EGFR, whereas gastric cancer displays distinct genetic changes. These data suggest that molecular diagnostics and targeted therapies can be applied to adenocarcinomas of the distal esophagus and gastroesophageal junction alike. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620594     DOI: 10.1016/j.cancergencyto.2010.03.013

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  16 in total

1.  CHD1L is a novel independent prognostic factor for gastric cancer.

Authors:  Z Su; J Zhao; G Xian; W Geng; Z Rong; Y Wu; C Qin
Journal:  Clin Transl Oncol       Date:  2013-11-21       Impact factor: 3.405

2.  Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Authors:  Hilda Wong; Thomas Yau
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

3.  Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway.

Authors:  Li-Min Feng; Xue-Feng Wang; Qing-Xian Huang
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

Review 4.  Clinical management of advanced gastric cancer: the role of new molecular drugs.

Authors:  Ferdinando De Vita; Natale Di Martino; Alessio Fabozzi; Maria Maddalena Laterza; Jole Ventriglia; Beatrice Savastano; Angelica Petrillo; Valentina Gambardella; Vincenzo Sforza; Luigi Marano; Annamaria Auricchio; Gennaro Galizia; Fortunato Ciardiello; Michele Orditura
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.

Authors:  William W Lockwood; Kelsie L Thu; Lin Lin; Larissa A Pikor; Raj Chari; Wan L Lam; David G Beer
Journal:  Clin Cancer Res       Date:  2012-02-10       Impact factor: 12.531

6.  Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma.

Authors:  Yang-Kun Wang; Zhong Chen; Tian Yun; Cong-Yang Li; Bo Jiang; Xue-Xia Lv; Guang-Hui Chu; Su-Nan Wang; Hui Yan; Lei-Feng Shi
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

7.  Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas.

Authors:  Yuan-Yuan Liu; Hai-Ying Chen; Man-Li Zhang; Dan Tian; Shibo Li; Ji-Yun Lee
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 8.  Gastric cancer-molecular and clinical dimensions.

Authors:  Roopma Wadhwa; Shumei Song; Ju-Seog Lee; Yixin Yao; Qingyi Wei; Jaffer A Ajani
Journal:  Nat Rev Clin Oncol       Date:  2013-09-24       Impact factor: 66.675

9.  CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression.

Authors:  Yunshan Wang; Mingxin Wen; Yongwon Kwon; Yangyang Xu; Yueyong Liu; Pengju Zhang; Xiuquan He; Qin Wang; Yurong Huang; Kuang-Yu Jen; Mark A LaBarge; Liang You; Scott C Kogan; Joe W Gray; Jian-Hua Mao; Guangwei Wei
Journal:  Cancer Res       Date:  2013-12-04       Impact factor: 12.701

10.  Identification of genes with a correlation between copy number and expression in gastric cancer.

Authors:  Lei Cheng; Ping Wang; Sheng Yang; Yanqing Yang; Qing Zhang; Wen Zhang; Huasheng Xiao; Hengjun Gao; Qinghua Zhang
Journal:  BMC Med Genomics       Date:  2012-05-04       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.